Roy Winston

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Roy Winston

The proxy statement of Pacira BioSciences, Inc. reports total compensation of $1,611,800 for Roy Winston in fiscal 2019, including a base salary of $408,654.

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Explain Roy Winston's disclosed executive compensation over time and cite the source filings.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Pacira BioSciences, Inc. (PCRX)
Proxy statement

Start not stated–2023-04-21

Last confirmed by a filing; no departure on record

Company network

Recorded roles and call appearances connecting this person to public companies.

Pacira BioSciences, Inc.

PCRX

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2019	Pacira BioSciences, Inc. (PCRX)	Chief Clinical Officer	$408,654	$225,000	$243,824	$720,919	—	$13,403	$1,611,800

Recent activity

No call appearances or filed executive changes recorded yet.